Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer

Anthracyclines, such as doxorubicin, are used as first-line chemotherapeutics, usually in combination therapies, for the treatment of advanced breast cancer. While these drugs have been successful therapeutic options, their use is limited due to serious drug related toxicities and acquired tumor res...

Celý popis

Podrobná bibliografia

Vydané v:	Translational oncology Ročník 11; číslo 4; s. 988 - 998
Hlavní autori:	Hasim, Mohamed S., Nessim, Carolyn, Villeneuve, Patrick J., Vanderhyden, Barbara C., Dimitroulakos, Jim
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Inc 01.08.2018 Elsevier
ISSN:	1936-5233, 1936-5233
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!